The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential
Texte intégral
Figure
Documents relatifs
The stimulating effect of 10 m M falcarindiol was blocked upon co- treatment with the PPARc antagonist T0070907 confirming the PPARc dependence of the observed activation (Fig.
Ta chute sera dure, ce ne sera pas du miel Quant à mon sourire, il sera sans peine Avoue, tu le mérites, t’es pas vraiment saine. T’as perdu l’habitude que l‘on te dise non
Beim sta bi len Pa ti en ten ist die Com pu ter- to mo gra phie (CT) die Stan dar dab klä rung, die beim stump fen Trau ma im Fal le ei ner ma kro sko pi schen Hä mat u rie
A mammalian one-hybrid assay was performed by transfecting HuH-7 cells with the J6-TK-Luc reporter vector, the hPPAR WT or α hPPAR K α 185 R expression vectors, and
To confirm this result, we measured the expression level of TSLP mRNA in independent experiments and system- atically found that TSLP mRNA level was significantly reduced by about
MESH Keywords Analysis of Variance ; Animals ; Anti-Inflammatory Agents ; pharmacology ; Aorta ; drug effects ; metabolism ; pathology ; Apolipoprotein E2 ;
Thérèse Hèrvée Mayi, Christian Duhem, Corinne Copin, Mohamed Amine Bouhlel, Elena Rigamonti, François Pattou, Bart Staels,
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of